Besides, EphA4 receptor is overexpressed in the EMT/stem‐like breast cancer cells (Lu et al., 2014) and Ephrin B2 is associated with progression and resistance to chemotherapy and radiation therapy in HNSCC (Oweida et al., 2017). Here, EFNB2 is linked to head and neck squamous cell carcinoma.